FDA issues Class I recall for Olympus endoscope needles
The Food and Drug Administration has identified a Class I recall of certain Olympus ViziShot 2 FLEX Needles due to a possible patient safety issue caused by a potentially deformed a-traumatic tip. The notice follows a previous report on a voluntary recall issued by Olympus Sept. 22. The defect impacts products manufactured before May 12. The FDA said there have been 14 reported injuries and one death associated with the issue.
Related News Articles
Headline
The Health Sector Coordinating Council’s Cybersecurity Working Group has released a guide on third-party artificial intelligence risk and AI supply…
Headline
The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients. The order imposes a…
Headline
AHA makes recommendations to CMS on strengthening domestic supply chain for PPE, essential medicines
The AHA today submitted comments to the Centers for Medicare & Medicaid Services on an advanced notice of proposed rulemaking on potential options to…
Headline
The Administration for Strategic Preparedness and Response March 24 announced an investment to expand the domestic manufacturing of propofol and metoprolol.…
Headline
The Administration for Strategic Preparedness and Response announced March 5 that it will invest in the domestic production of thebaine, an ingredient…
Headline
The Supreme Court Feb. 20 ruled that the International Emergency Economic Powers Act does not authorize the imposition of global tariffs. The court held that…